Airway Medix S.A. entra nella fase commerciale con il primo ordine internazionale
Il 3 dicembre 2025 Airway Medix ha ricevuto dal suo partner di distribuzione latinoamericano il primo ordine commerciale, per B-Care Oral Care e Cuffix. L'ordine segna l'inizio della fase commerciale, con una produzione interamente in Europa.
Testo completo in inglese (originale)
Warsaw, December 5, 2025: Airway Medix S.A. (WSE: AWM), an innovative MedTech company focused on advanced disposable devices for mechanically ventilated patients, announces the receipt of its first commercial order under previously executed distribution agreements for its B-Care Oral Care and Cuffix devices.
On December 3, 2025, Airway Medix received its first commercial order from a company based in Latin America active in the distribution and sale of medical equipment. The order covers the Oral Care and Cuffix product lines and marks the beginning of commercial sales based on distribution contracts previously disclosed in current reports.
This milestone follows a series of key steps completed in recent months, including product certification, obtaining the ISO 13485 quality management system certificate, and the transfer of full production to Europe, which enabled the company to reach full manufacturing readiness.
"Receiving the first commercial order under our new distribution agreements is a clear validation of the business transformation we have been executing," said Anna Aranowska-Bablok, Chief Executive Officer of Airway Medix S.A. "It confirms that the investments in certification, quality systems and European manufacturing capacity are translating into revenue-generating commercialization of our portfolio, and it strengthens our confidence in the scalability of our model as we work to build a broader base of stable, recurring sales."
In line with its communicated focus on transforming from a research and development-focused entity into a fully functioning international commercial company, Airway Medix has significantly strengthened its sales and marketing team. The development of organic sales has become one of the company's key operational priorities.
About Airway Medix S.A.: Airway Medix S.A. focuses on the research, development and commercialization of innovative disposable devices for mechanically ventilated patients in Intensive Care Units (ICUs), as well as life-threatening patients and anesthesiology departments. The products offered by Airway Medix address the most pressing clinical needs and fill a gap in current medical devices. Airway Medix S.A. has been listed on the Warsaw Stock Exchange since 2014.
I comunicati stampa sono pubblicati così come emessi da Airway Medix S.A. Le dichiarazioni sui prodotti sono conformi alle istruzioni per l'uso.
